Selvita vs Sygnature Discovery

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/selvita/sygnaturediscovery

Category	Selvita	Sygnature Discovery
Listed site	cro	cro
Summary	Selvita is an integrated drug discovery and development service provider offering comprehensive solutions from target validation through preclinical candidate nomination and clinical manufacturing, with expertise in small molecules, antibodies, and protein degraders.	Integrated drug discovery CRO covering target identification through lead optimization, with computational design, structural biology, medicinal chemistry and DMPK support. Serves biotech and pharma clients across the US, Canada, UK and Europe.
Services	Bioinformatics & Data Science Computational & In-Silico Drug Discovery Medicinal Chemistry High-Throughput Screening Target Identification & Validation Discovery Research In Vitro Pharmacology In Vitro ADME / DMPK Preclinical In Vitro Studies In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vivo Studies Analytical Method Development & Validation ICH Stability Studies Regulatory Affairs Bioanalysis LC-MS Bioanalysis (Small Molecule) Protein Engineering Microbiology Services	Target Identification & Validation Discovery Research Medicinal Chemistry Computational & In-Silico Drug Discovery Bioinformatics & Data Science In Vitro ADME / DMPK Preclinical In Vivo Studies
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Peptide	Small Molecule Biologics (Monoclonal Antibodies)
Indications	Oncology Respiratory Neurology Metabolic Infectious Disease Gastroenterology Immunology	Data not yet provided.
Locations	Data not yet provided.	UK site, United Kingdom Canada site, Canada
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.